TF Financial Corp (THRD) Peer Comparison

$5.38

$0.00 (0.00%)

As on 13-Aug-2025 09:30EDT

Market cap

$243 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Edit

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Market cap ($ Mln)	243	77
Revenue ($ Mln)	0	145
Net Profit ($ Mln)	-53.45	-53.39
Net Margin (%)	-111,347.92	-36.80
RoE (%)	-18.84	-71.61
Price to Earnings	--	--
Price-To-Book	0.89	0.76

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Operating Revenue	0.05	145.05
Cost of Revenue	0.04	2.79
Gross Profit	-0.05	-6.43
Operating Expenses	66.29	172.46
Operating Profit (EBIT)	-66.30	-27.85
Other Income	0.00	0.00
Profit before Tax	-53.45	-53.39
Provision for Tax	0.00	0.00
Profit after Tax (Net Income)	-53.45	-53.39
Minority Interest	0.00	0.00
Consolidated Profit	0.00	0.00

Liabilities ($ Mln)

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Shareholder's Funds	272.62	100.93
Minority Interest	0.00	0.00
Non-Current Liabilities	2.11	0.00
Current Liabilities	5.10	6.06
Total Liabilities	294.61	265.71

Assets ($ Mln)

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Non-Current Assets	3.84	0.00
Current Assets	276.00	106.99
Total Assets	294.61	265.71
Total Debt*	3.00	0.00
Net Current Assets	270.90	100.93

Cashflow ($ Mln)

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Cash From Operating Activities	-34.50	-153.00
Cash Flow from Investing Activities	-0.01	64.16
Cash from Financing Activities	50.51	2.39
Net Cash Inflow / Outflow	--	--

Ratios

Profitability Ratios

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
ROCE (%)	16.20	-116.17
ROE (%)	-18.84	-71.61
ROA (%)	-19.11	-21.91
EBIT Margin (%)	-138,120.83	-26.66
Net Margin (%)	-111,347.92	-36.80
Cash Profit Margin (%)	-2.23	0.00

Growth Ratios

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Revenue Growth (%)	-94.26	4,882.82
EBIT Growth (%)	-52.70	83.69
Net Profit Growth (%)	-258.49	75.78
EPS Growth (%)	-240.21	75.44
Book Value Growth (%)	-7.37	-19.27

Valuation Ratios

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Price / Earnings	9.35	-1.89
Price / Book Value	1.49	7.68
Dividend Yield (%)	--	--
EV/EBITDA	-3.16	-1.16
Market Cap ($ Cr)	--	--

Solvency Ratios

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Debt to Equity	0.00	0.00
Short term debt to equity ratio	0.00	0.00
Current Ratio	54.10	17.66
Quick Ratio	54.10	17.66
Interest Coverage	--	--

Operating Efficiency Ratios

	TF Financial Corp (THRD)	IGM Biosciences (IGMS)
Debtors to sales (%)	0.00	0.34
Asset Turnover	0.00	0.60
Receivable days	--	109.07
Inventory Days	--	--
Payable days	14,069.58	46.28
Cash Conversion Cycle	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly